CN109535223A - A kind of method of double titanium functional magnetic nano material separating and enriching phosphated peptides - Google Patents
A kind of method of double titanium functional magnetic nano material separating and enriching phosphated peptides Download PDFInfo
- Publication number
- CN109535223A CN109535223A CN201811254427.9A CN201811254427A CN109535223A CN 109535223 A CN109535223 A CN 109535223A CN 201811254427 A CN201811254427 A CN 201811254427A CN 109535223 A CN109535223 A CN 109535223A
- Authority
- CN
- China
- Prior art keywords
- magnetic nano
- functional magnetic
- titanium
- nano material
- double
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 71
- 239000002086 nanomaterial Substances 0.000 title claims abstract description 67
- 239000010936 titanium Substances 0.000 title claims abstract description 65
- 229910052719 titanium Inorganic materials 0.000 title claims abstract description 65
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 title claims abstract description 60
- 238000000034 method Methods 0.000 title claims abstract description 27
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 16
- 239000012488 sample solution Substances 0.000 claims abstract description 16
- 238000002955 isolation Methods 0.000 claims abstract description 15
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000000908 ammonium hydroxide Substances 0.000 claims abstract description 14
- 239000003480 eluent Substances 0.000 claims abstract description 11
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 4
- 238000002525 ultrasonication Methods 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000000243 solution Substances 0.000 claims description 25
- 239000008367 deionised water Substances 0.000 claims description 21
- 229910021641 deionized water Inorganic materials 0.000 claims description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 19
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 18
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 16
- 229960004756 ethanol Drugs 0.000 claims description 12
- 235000019441 ethanol Nutrition 0.000 claims description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 8
- 229910010413 TiO 2 Inorganic materials 0.000 claims description 8
- 229960005305 adenosine Drugs 0.000 claims description 8
- 239000002243 precursor Substances 0.000 claims description 8
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 239000011259 mixed solution Substances 0.000 claims description 7
- DCKVFVYPWDKYDN-UHFFFAOYSA-L oxygen(2-);titanium(4+);sulfate Chemical compound [O-2].[Ti+4].[O-]S([O-])(=O)=O DCKVFVYPWDKYDN-UHFFFAOYSA-L 0.000 claims description 7
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 7
- 229910000348 titanium sulfate Inorganic materials 0.000 claims description 7
- 238000001027 hydrothermal synthesis Methods 0.000 claims description 6
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 6
- 238000002604 ultrasonography Methods 0.000 claims description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 150000003608 titanium Chemical class 0.000 claims description 4
- QDZRBIRIPNZRSG-UHFFFAOYSA-N titanium nitrate Chemical compound [O-][N+](=O)O[Ti](O[N+]([O-])=O)(O[N+]([O-])=O)O[N+]([O-])=O QDZRBIRIPNZRSG-UHFFFAOYSA-N 0.000 claims description 4
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical group CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 claims description 4
- YHWCPXVTRSHPNY-UHFFFAOYSA-N butan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCC[O-].CCCC[O-].CCCC[O-].CCCC[O-] YHWCPXVTRSHPNY-UHFFFAOYSA-N 0.000 claims description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 229940040526 anhydrous sodium acetate Drugs 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 238000010189 synthetic method Methods 0.000 claims description 2
- 238000005660 chlorination reaction Methods 0.000 claims 1
- 230000026731 phosphorylation Effects 0.000 abstract description 18
- 238000006366 phosphorylation reaction Methods 0.000 abstract description 18
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 abstract description 12
- 239000000463 material Substances 0.000 abstract description 12
- 108010033276 Peptide Fragments Proteins 0.000 abstract description 9
- 102000007079 Peptide Fragments Human genes 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 239000004408 titanium dioxide Substances 0.000 abstract description 6
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 230000009822 protein phosphorylation Effects 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 3
- LCKIEQZJEYYRIY-UHFFFAOYSA-N Titanium ion Chemical compound [Ti+4] LCKIEQZJEYYRIY-UHFFFAOYSA-N 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000007306 functionalization reaction Methods 0.000 abstract 1
- 102000011632 Caseins Human genes 0.000 description 15
- 108010076119 Caseins Proteins 0.000 description 15
- 235000021247 β-casein Nutrition 0.000 description 13
- 239000000523 sample Substances 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 238000001819 mass spectrum Methods 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 210000003296 saliva Anatomy 0.000 description 7
- 229910021645 metal ion Inorganic materials 0.000 description 6
- 230000000865 phosphorylative effect Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000010183 spectrum analysis Methods 0.000 description 6
- 239000003463 adsorbent Substances 0.000 description 5
- 238000001042 affinity chromatography Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 239000007790 solid phase Substances 0.000 description 5
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000005352 clarification Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000009977 dual effect Effects 0.000 description 4
- 238000004503 metal oxide affinity chromatography Methods 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 108010042653 IgA receptor Proteins 0.000 description 3
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 108091005981 phosphorylated proteins Proteins 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- MQRJBSHKWOFOGF-UHFFFAOYSA-L disodium;carbonate;hydrate Chemical compound O.[Na+].[Na+].[O-]C([O-])=O MQRJBSHKWOFOGF-UHFFFAOYSA-L 0.000 description 1
- IYAMYECUTLASCU-UHFFFAOYSA-L disodium;ethanol;carbonate Chemical compound [Na+].[Na+].CCO.[O-]C([O-])=O IYAMYECUTLASCU-UHFFFAOYSA-L 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- LSDSZZKMMNCFMR-UHFFFAOYSA-N nitric acid titanium Chemical compound [Ti].O[N+]([O-])=O LSDSZZKMMNCFMR-UHFFFAOYSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Compounds Of Iron (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811254427.9A CN109535223B (en) | 2018-10-26 | 2018-10-26 | Method for separating and enriching phosphorylated peptide by using double-titanium functionalized magnetic nano material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811254427.9A CN109535223B (en) | 2018-10-26 | 2018-10-26 | Method for separating and enriching phosphorylated peptide by using double-titanium functionalized magnetic nano material |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109535223A true CN109535223A (en) | 2019-03-29 |
CN109535223B CN109535223B (en) | 2022-01-28 |
Family
ID=65845617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811254427.9A Active CN109535223B (en) | 2018-10-26 | 2018-10-26 | Method for separating and enriching phosphorylated peptide by using double-titanium functionalized magnetic nano material |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109535223B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110156869A (en) * | 2019-04-11 | 2019-08-23 | 复旦大学 | A kind of method of specific isolation enrichment endogenous Phosphorylated Peptide |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101054406A (en) * | 2007-05-24 | 2007-10-17 | 复旦大学 | Method of separating and enriching phosphated peptide section by metal oxide magnetic micro-sphere |
WO2008148645A1 (en) * | 2007-06-07 | 2008-12-11 | Syddansk Universitet | Separation of mono- from multi-phoshorylated peptides |
US20100093102A1 (en) * | 2008-09-26 | 2010-04-15 | Song Jin | Mesoporous metal oxide materials for phosphoproteomics |
CN103495376A (en) * | 2013-10-08 | 2014-01-08 | 江南大学 | Preparation and phosphoeptide enrichment methods of titanium dioxide/ferroferric oxide nanoparticles |
CN105561957A (en) * | 2015-12-10 | 2016-05-11 | 复旦大学 | Titanium-zirconium double-metal-atom horizontally-doped honeycomb-shaped mesoporous composite material as well as synthesis method and application of titanium-zirconium double-metal-atom horizontally-doped honeycomb-shaped mesoporous composite material |
CN108440641A (en) * | 2018-02-07 | 2018-08-24 | 复旦大学 | A kind of method of specific isolation enriching phosphated peptide and glycosylated peptide |
-
2018
- 2018-10-26 CN CN201811254427.9A patent/CN109535223B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101054406A (en) * | 2007-05-24 | 2007-10-17 | 复旦大学 | Method of separating and enriching phosphated peptide section by metal oxide magnetic micro-sphere |
WO2008148645A1 (en) * | 2007-06-07 | 2008-12-11 | Syddansk Universitet | Separation of mono- from multi-phoshorylated peptides |
US20100093102A1 (en) * | 2008-09-26 | 2010-04-15 | Song Jin | Mesoporous metal oxide materials for phosphoproteomics |
CN103495376A (en) * | 2013-10-08 | 2014-01-08 | 江南大学 | Preparation and phosphoeptide enrichment methods of titanium dioxide/ferroferric oxide nanoparticles |
CN105561957A (en) * | 2015-12-10 | 2016-05-11 | 复旦大学 | Titanium-zirconium double-metal-atom horizontally-doped honeycomb-shaped mesoporous composite material as well as synthesis method and application of titanium-zirconium double-metal-atom horizontally-doped honeycomb-shaped mesoporous composite material |
CN108440641A (en) * | 2018-02-07 | 2018-08-24 | 复旦大学 | A kind of method of specific isolation enriching phosphated peptide and glycosylated peptide |
Non-Patent Citations (2)
Title |
---|
KASPER ENGHOLM-KELLER ET AL.: ""Titanium dioxide as chemo-affinity chromatographic sorbent of biomolecular compounds-Applications in acidic modification-specific proteomics"", 《JOURNAL OF PROTEOMICS》 * |
徐林楠 等: ""磷酸化肽富集新方法研究进展"", 《分析化学》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110156869A (en) * | 2019-04-11 | 2019-08-23 | 复旦大学 | A kind of method of specific isolation enrichment endogenous Phosphorylated Peptide |
Also Published As
Publication number | Publication date |
---|---|
CN109535223B (en) | 2022-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Highly selective and rapid enrichment of phosphorylated peptides using gallium oxide‐coated magnetic microspheres for MALDI‐TOF‐MS and nano‐LC‐ESI‐MS/MS/MS analysis | |
CN103894161B (en) | A kind of synthetic method of magnetic metal organic framework composite material and application thereof | |
Huang et al. | Enrichment and separation techniques for large-scale proteomics analysis of the protein post-translational modifications | |
CN105363426B (en) | A kind of method of meso-porous titanium dioxide silicon composite connexus spectrum identification peptide fragment | |
Leitner et al. | Tools for analyzing the phosphoproteome and other phosphorylated biomolecules: a review | |
CN106512965A (en) | Synthetic method and application of metal-organic framework composite nanomaterial | |
CN108440641A (en) | A kind of method of specific isolation enriching phosphated peptide and glycosylated peptide | |
CN105536748B (en) | A kind of method of nanocomposite combination Mass Spectrometric Identification phosphated peptide section | |
Sun et al. | Hydrophilic Nb5+-immobilized magnetic core–shell microsphere–A novel immobilized metal ion affinity chromatography material for highly selective enrichment of phosphopeptides | |
Lin et al. | Development of immobilized Sn4+ affinity chromatography material for highly selective enrichment of phosphopeptides | |
CN103940894A (en) | Method for simultaneously enriching phosphopeptides and glycopeptides and performing mass spectrometry | |
US7250266B2 (en) | Selective labeling agent for phosphoproteome analysis and phosphorylated site analysis | |
CN106770614B (en) | The method of hydrophilic nanometer composite material combination mass spectral analysis identification glycopeptide segment | |
JP2004516486A (en) | Reverse labeling method for rapid marker / target protein identification | |
Zhao et al. | Isolation of phosphopeptides using zirconium-chlorophosphonazo chelate-modified silica nanoparticles | |
CN102818836B (en) | Sequential separation and mass spectrum identification method of multi-site phosphorylation peptide | |
CN109535223A (en) | A kind of method of double titanium functional magnetic nano material separating and enriching phosphated peptides | |
Hussain et al. | Development of diamond-lanthanide metal oxide affinity composites for the selective capture of endogenous serum phosphopeptides | |
Zhao et al. | Zirconium arsenate-modified silica nanoparticles for specific capture of phosphopeptides and direct analysis by matrix-assisted laser desorption/ionization mass spectrometry | |
Johnson et al. | Analysis of post-translational modifications by LC-MS/MS | |
CN106478768A (en) | A kind of N- phosphorylation peptide gathering method | |
Hussain et al. | Facile liquid-phase deposition synthesis of titania-coated magnetic sporopollenin for the selective capture of phosphopeptides | |
CN110609078B (en) | Method for detecting protein phosphorylation and acetylglucosamine saccharification correlation effect | |
Yu et al. | Preparation of magnetic hydroxyapatite clusters and their application in the enrichment of phosphopeptides | |
JP2009121857A (en) | Phosphorylated peptide measuring method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240702 Address after: 201900 zone a, floor 5, building 1, No. 668, SHANGDA Road, Baoshan District, Shanghai Patentee after: Shanghai Fujie Technology Co.,Ltd. Country or region after: China Address before: 200433 No. 220, Handan Road, Shanghai, Yangpu District Patentee before: FUDAN University Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240722 Address after: 201800 J, building 6, 1288 Yecheng Road, Jiading District, Shanghai Patentee after: Shanghai Fuiridium Biotechnology Co.,Ltd. Country or region after: China Address before: 201900 zone a, floor 5, building 1, No. 668, SHANGDA Road, Baoshan District, Shanghai Patentee before: Shanghai Fujie Technology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |